M. Redfield

Cardiology and Cardiovascular Medicine · 2000–2019

A researcher in the Science corpus: 21 papers; trusts 4 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Whom M. Redfield trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Steve R. Ommen
  2. Rick A. Nishimura
  3. Barry A. Borlaug

Who trusts M. Redfield overall

  1. Véronique L. Roger
  2. Barry A. Borlaug
  3. C. Yancy
  4. Sherif F. Nagueh
  5. Douglas W. Mahoney
  6. W. Paulus
  7. Steven Jacobsen

Papers from M. Redfield's perspective

Ordered by how strongly the researchers M. Redfield trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Perceived Exertion (Sports Medicine)
  2. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart… (Journal of the American College of Cardiology)
  3. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. (Circulation)
  4. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. (Journal of the American Medical Association (JAMA))
  5. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000-2010 (JAMA Internal Medicine)
  6. Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure (Circulation)
  7. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. (Journal of the American College of Cardiology)
  8. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease (Circulation)
  9. Trends in prevalence and outcome of heart failure with preserved ejection fraction. (New England Journal of Medicine)
  10. Irbesartan in patients with heart failure and preserved ejection fraction. (New England Journal of Medicine)

Their papers